Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Glycoprotein – e.g. – mucins – proteoglycans – etc.
Patent
1993-02-19
1995-03-07
Wityshyn, Michael G.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Glycoprotein, e.g., mucins, proteoglycans, etc.
5303892, 530402, 530370, 530408, 530409, 5303917, 4241781, 4241821, C07K 300, A61K 3900
Patent
active
053959248
ABSTRACT:
An activated affinity ligand is described comprising: a ligand having (a) a region with affinity for binding sites of a lectin; and (b) a reactive group capable of covalently linking the ligand to the lectin to thereby block one or more of the binding sites of the lectin. A blocked lectin is described comprising one or more affinity ligands covalently linked by means of a reactive group present on each of the ligands to a lectin such that one or more binding sites of the lectin is blocked. A cell-binding agent-blocked lectin conjugate is described comprising the above-described blocked lectin and a cell-binding agent covalently linked to: (a) one of the covalently linked affinity ligands; or (b) the lectin. A method of preparing the cell-binding agent-blocked lectin conjugate is described. An affinity support capable of binding to a lectin to form a blocked lectin is described comprising an activated affinity ligand covalently linked to a solid support. A method of preparing the affinity support capable of binding to a lectin to form a blocked lectin is described. A method of killing selected cell populations having reduced cytotoxicity to non-selected cell populations is described comprising contacting a cell population or tissue suspected of containing cells from said selected cell population with the above-described cell-binding agent-blocked lectin conjugate, wherein the lectin is a cytotoxic lectin. Medicaments and methods of treatment using the above-described cell-binding agent-blocked lectin conjugate also are described.
REFERENCES:
patent: 4206094 (1980-06-01), Yen et al.
patent: 4289747 (1981-09-01), Chu
patent: 4320194 (1982-03-01), Bull
patent: 4340535 (1982-07-01), Voisin
patent: 4359457 (1982-11-01), Neville, Jr.
patent: 4371515 (1983-02-01), Chu
patent: 4440747 (1984-04-01), Neville, Jr. et al.
patent: 4450154 (1984-05-01), Masuho et al.
patent: 4493793 (1985-01-01), Chu
patent: 4590071 (1986-05-01), Scannon et al.
patent: 4590211 (1986-05-01), Voorhees et al.
patent: 4625014 (1986-11-01), Senter et al.
patent: 4631190 (1986-12-01), Shen et al.
patent: 4647655 (1987-03-01), Axen et al.
patent: 4664911 (1987-05-01), Uhr et al.
patent: 4689311 (1987-08-01), Weltman
Moroney et al., "Modification of the Binding Site(s) of Lectins by an Affinity Column Carrying an Activated Galactose-Terminated Ligand", Biochemistry, vol. 26, (1987) pp. 8390-8398.
Houston, "Inactivation of Ricin Using 4.varies.Azidophenyl-.beta.-D-Galactopyranoside and 4-Diazophenyl-.beta.-D-Galactopyranoside", J. Biol. Chem., vol. 258, No. 11, (Jun. 1983) pp. 7208-7212.
Baenziger and Fiete, "Photoactivatable Glycopeptide Reagents for Site-Specific Labeling of Lectins", J. Bio. Chem., vol. 257, No. 8, (1982) pp. 4421-4425.
Youle et al., "Studies on the Galactose-Binding Site of Ricin and the Hybrid Toxin Man6P-Ricin", Cell, vol. 23, (Feb. 1981) pp. 551-559.
Lee and Lee, "Chapter 34, Cluster Glycosides", Methods in Enzymology, vol. 138, (1987) pp. 424-429.
Lee et al., "New Synthetic Cluster Ligands for Galactose/N-Acetylgalactosamine-Specific Lactin of Mammalian", Biochemistry, vol. 23, (1984) pp. 4255-4261.
Lee et al., "Binding of Synthetic Oligosaccharides to the Hepatic Gal/GalNAc Lectin", J. Biol. Chem., vol. 258, No. 1, (Jan. 19, 1983) pp. 199-202.
Lee and Lee, "Preparation of a High-Affinity Photolabeling Reagent for the Gel/GalNAc Lectin of Mammalian Liver: Demonstration of Galactose-Combining Sites on Each Subunit of Rabbit Hepatic Lectin", Biochemistry, vol. 25, (1986) pp. 6835-6841.
Townsend et al., "Binding of N-Linked Bovine Feutin Glycopeptides to Isolated Rabbit Hepatocytes: Gal/GalNAc Hepatic Lectin Discrimination Between Gal.beta.(1,4)GlcNAc and Gal.beta.(1,3)GlcNAc in a Triantennary Structure", Biochemistry, vol. 25, (1986) pp. 5716-5725.
Mertens et al., "A Lectin Cell Binding Assay", Protides Biol. Fluids, vol. 31, (1983) pp. 1093-1096 cited in Chemical Abstracts, vol. 101, (1984) 21690u.
Thorpe et al., "Blockade of the Galactose-Binding Sites of Ricin by its Linkage to Antibody", Eur. J. Biochem. vol. 140 (1984) pp. 63-71.
Blair and Ghose, "Linkage of Cytotoxic Agents to Immunoglobulins", J. Immun. Methods, vol. 59, (1983) pp. 129-143.
Blattler Walter A.
Chari Ravi V. J.
Collison Albert R.
Goldmacher Victor S.
Kostuba Linda J.
Dana-Farber Cancer Institute Inc.
Mohamed Abdel A.
Wityshyn Michael G.
LandOfFree
Blocked lectins; methods and affinity support for making the sam does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blocked lectins; methods and affinity support for making the sam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blocked lectins; methods and affinity support for making the sam will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1406874